EU CEP & FDA Certified, Delivering Domestic Alternative for High-End Pharmaceutical Excipients

GUANGZHOU, CHINA – 2026 – Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd., a leading provider of high-end pharmaceutical lipid excipients, specialty APIs, and health products, today reaffirms its position as a trusted supplier of EP-grade egg yolk lecithin for global pharmaceutical markets. This domestically developed product breaks long-term international monopolies in high-end lipid excipients, featuring green extraction technology and full compliance with global regulatory standards. It serves over 1,000 clients worldwide, including top pharmaceutical firms like B. Braun and AstraZeneca, and is available via direct sales, distribution, and custom processing channels .

Core Technological Breakthroughs & Product Advantages

Guangzhou Baiyunshan Hanfang has achieved a critical technological breakthrough with its EP-grade egg yolk lecithin, developed using an integrated green technology combining supercritical CO₂ extraction, membrane separation, and chromatographic separation. This process replaces traditional polluting methods, ensuring product purity and reducing environmental impact. The product has increased the localization rate of high-end pharmaceutical lipid excipients in China from 10% to 90%, eliminating reliance on imported alternatives. As of 2025, the company holds over 240 patents related to lipid excipient technology, solidifying its technical barrier in the industry .

Global Compliance & Certifications

The EP-grade egg yolk lecithin meets stringent international standards, holding certifications including EU CEP, US FDA US-DMF, Mexico Cofepris, and India DCGI. The company also boasts top-tier national qualifications, such as being the only national engineering research center for pharmaceutical lipids in China, a national specialized and sophisticated "Little Giant" enterprise, and a recipient of the National May Day Labor Award. These credentials ensure the product meets regulatory requirements in over 20 countries and regions worldwide .

Supply & Customization Services

Guangzhou Baiyunshan Hanfang offers flexible supply options for its EP-grade egg yolk lecithin, including direct sales, agent distribution, and custom processing. The company’s marketing network covers 31 provinces and cities across China, with products exported to over 20 countries. It provides tailored solutions to meet specific requirements of pharmaceutical manufacturers, supporting the development of high-end formulations and generic drugs .

Executive Quote

"Our EP-grade egg yolk lecithin represents a key milestone in China's pharmaceutical excipient localization drive," said Xu Wendong, General Manager and Deputy Director of the National Engineering Research Center at Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd. "By leveraging green extraction technologies, we not only ensure product safety and quality but also provide cost-effective alternatives for global pharmaceutical partners, strengthening supply chain resilience ."

Industry Context & Strategic Alignment

High-end pharmaceutical lipid excipients have long been dominated by international suppliers, creating supply chain vulnerabilities for global drug manufacturers. Guangzhou Baiyunshan Hanfang’s localized production addresses this gap, aligning with global trends toward supply chain independence and sustainable manufacturing. The company’s focus on technological innovation supports China’s goal of achieving self-reliance in key pharmaceutical components .

Future Plans

Looking ahead, Guangzhou Baiyunshan Hanfang will continue to invest in R&D for pharmaceutical lipid excipients, expanding its product portfolio and global market reach. The company targets double-digit growth in revenue and profit in 2026, as part of its "four modernizations" development path to become a trusted global health guardian .

About Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd.

Founded in 1998, Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd. is a state-owned enterprise under the Guangzhou Pharmaceutical Holdings Group, specializing in high-end pharmaceutical lipid excipients, specialty APIs, health products, and technical services. It operates a national engineering research center and a provincial key laboratory for pharmaceutical lipids, with over 330 employees including 11 PhDs and national-level experts. The company serves over 1,000 clients worldwide and holds over 240 patents, with products exported to more than 20 countries .

Contact Information

Company: Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd.
Official Website: http://byshanhanfang.com/

© 2026 Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd. All rights reserved .